Skip to main content
. Author manuscript; available in PMC: 2014 May 20.
Published in final edited form as: Clin Cancer Res. 2011 Jul 7;17(16):5367–5378. doi: 10.1158/1078-0432.CCR-10-3176

Figure 1. Clinical significance of mucinous ovarian carcinomas.

Figure 1

(A) Proportion of FIGO stage in 122 mucinous (black bar) and 698 serous (white bar) carcinoma patients is shown. (B) Proportion of patients with elevated CA-125 (>35 IU/L) and median CA-125 value among patients with mucinous or serous carcinomas are shown. Bar for CA125 >35 IU/L represents frequency with 95%CI. (C) Kaplan-Meier survival curves for progression-free survival and overall survival in early-stage disease are shown. (D) Kaplan-Meier survival curves for overall survival and survival time after progression or recurrence of disease are shown.